ES8609311A1 - Procedimiento para obtencion de derivados de flavolignano - Google Patents

Procedimiento para obtencion de derivados de flavolignano

Info

Publication number
ES8609311A1
ES8609311A1 ES549116A ES549116A ES8609311A1 ES 8609311 A1 ES8609311 A1 ES 8609311A1 ES 549116 A ES549116 A ES 549116A ES 549116 A ES549116 A ES 549116A ES 8609311 A1 ES8609311 A1 ES 8609311A1
Authority
ES
Spain
Prior art keywords
derivatives
formula
sibilinin
flavolignan
alk1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549116A
Other languages
English (en)
Spanish (es)
Other versions
ES549116A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Dr Madaus GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co filed Critical Dr Madaus GmbH and Co
Publication of ES549116A0 publication Critical patent/ES549116A0/es
Publication of ES8609311A1 publication Critical patent/ES8609311A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
ES549116A 1984-11-22 1985-11-21 Procedimiento para obtencion de derivados de flavolignano Expired ES8609311A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
ES549116A0 ES549116A0 (es) 1986-09-01
ES8609311A1 true ES8609311A1 (es) 1986-09-01

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549116A Expired ES8609311A1 (es) 1984-11-22 1985-11-21 Procedimiento para obtencion de derivados de flavolignano

Country Status (29)

Country Link
JP (1) JPS61143377A (enrdf_load_stackoverflow)
KR (1) KR870001020B1 (enrdf_load_stackoverflow)
AR (1) AR240931A1 (enrdf_load_stackoverflow)
AT (1) AT393268B (enrdf_load_stackoverflow)
BE (1) BE903693A (enrdf_load_stackoverflow)
CA (1) CA1337124C (enrdf_load_stackoverflow)
CH (1) CH659473A5 (enrdf_load_stackoverflow)
CS (1) CS273610B2 (enrdf_load_stackoverflow)
DD (1) DD259191A1 (enrdf_load_stackoverflow)
DE (1) DE3442639A1 (enrdf_load_stackoverflow)
DK (1) DK164865C (enrdf_load_stackoverflow)
EG (1) EG19424A (enrdf_load_stackoverflow)
ES (1) ES8609311A1 (enrdf_load_stackoverflow)
FI (1) FI84064C (enrdf_load_stackoverflow)
FR (1) FR2573427B1 (enrdf_load_stackoverflow)
GB (1) GB2167414B (enrdf_load_stackoverflow)
HU (1) HU195503B (enrdf_load_stackoverflow)
IE (1) IE58791B1 (enrdf_load_stackoverflow)
IT (1) IT1190426B (enrdf_load_stackoverflow)
LU (1) LU86163A1 (enrdf_load_stackoverflow)
MX (1) MX168415B (enrdf_load_stackoverflow)
NL (1) NL192387C (enrdf_load_stackoverflow)
NO (1) NO160205C (enrdf_load_stackoverflow)
PL (1) PL146890B1 (enrdf_load_stackoverflow)
PT (1) PT81532B (enrdf_load_stackoverflow)
SE (1) SE465676B (enrdf_load_stackoverflow)
SU (1) SU1436875A3 (enrdf_load_stackoverflow)
YU (1) YU43689B (enrdf_load_stackoverflow)
ZA (1) ZA858951B (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
ES2552108T3 (es) * 2005-03-11 2015-11-25 Howard Florey Institute Pty Ltd Compuestos flavonoides y usos de los mismos
WO2009062737A1 (en) * 2007-11-15 2009-05-22 Madaus Gmbh Silibinin component for the treatment of hepatitis
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
TWI529167B (zh) 2009-05-14 2016-04-11 歐羅梅德股份有限公司 用於治療病毒性肝炎之非晶型水飛薊賓
RU2666953C2 (ru) 2012-07-05 2018-09-13 Нутрамакс Лабораториз, Инк. Композиции, содержащие сульфорафан или предшественник сульфорафана и экстракт или порошок молочного чертополоха
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
DD259191A1 (de) 1988-08-17
LU86163A1 (de) 1986-03-24
CS837885A2 (en) 1990-08-14
FR2573427A1 (fr) 1986-05-23
DE3442639A1 (de) 1986-05-22
AR240931A1 (es) 1991-03-27
ES549116A0 (es) 1986-09-01
NO854655L (no) 1986-05-23
FR2573427B1 (fr) 1989-03-10
DK164865B (da) 1992-08-31
HU195503B (en) 1988-05-30
FI84064B (fi) 1991-06-28
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
NO160205C (no) 1989-03-22
AT393268B (de) 1991-09-25
BE903693A (fr) 1986-05-22
EG19424A (en) 1995-02-28
JPS61143377A (ja) 1986-07-01
DE3442639C2 (enrdf_load_stackoverflow) 1989-08-10
FI854535A7 (fi) 1986-05-23
DK164865C (da) 1993-01-18
PT81532A (de) 1985-12-01
GB8528226D0 (en) 1985-12-18
YU178685A (en) 1988-02-29
AR240931A2 (es) 1991-03-27
ZA858951B (en) 1986-08-27
NL8503171A (nl) 1986-06-16
CH659473A5 (de) 1987-01-30
JPH0432073B2 (enrdf_load_stackoverflow) 1992-05-28
IE58791B1 (en) 1993-11-17
MX168415B (es) 1993-05-24
KR870001020B1 (ko) 1987-05-23
SU1436875A3 (ru) 1988-11-07
NO160205B (no) 1988-12-12
IT8522932A0 (it) 1985-11-21
FI84064C (fi) 1991-10-10
KR860004056A (ko) 1986-06-16
HUT40114A (en) 1986-11-28
PL256374A1 (en) 1986-12-02
SE8505487D0 (sv) 1985-11-20
DK537785D0 (da) 1985-11-21
YU43689B (en) 1989-10-31
GB2167414A (en) 1986-05-29
GB2167414B (en) 1989-01-11
FI854535A0 (fi) 1985-11-18
NL192387C (nl) 1997-07-04
PT81532B (pt) 1987-11-11
IE852808L (en) 1986-05-22
IT1190426B (it) 1988-02-16
NL192387B (nl) 1997-03-03
CA1337124C (en) 1995-09-26
CS273610B2 (en) 1991-03-12
ATA337185A (de) 1991-02-15
DK537785A (da) 1986-05-23
SE8505487L (sv) 1986-05-23

Similar Documents

Publication Publication Date Title
ES8609311A1 (es) Procedimiento para obtencion de derivados de flavolignano
ES453455A1 (es) Procedimiento de preparacion de derivados de poliprenilo.
ES2067248T3 (es) Derivados de indol como agentes antialergicos y antiinflamatorios.
ES8405274A1 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
ES394369A1 (es) Procedimiento para la preparacion de derivados de la isoin-dolina.
PT798309E (pt) Agente diagnostico para a funcao glicometabolica
DK624586D0 (da) 10beta-alkynylaestrenderivater og fremgangsmaade til fremstilling deraf
BG32418A3 (en) Method for obtaining of amid derivatives of 1, 2, 3- thiadiazol- 5- carbonic acid
ES2052494T3 (es) Procedimiento para preparar polvos metalicos finamente divididos.
DE3869825D1 (de) Quaternaere ammonium-retinoate, ihre verwendung in der kosmetik und dermopharmazie.
DK0425283T3 (da) Triazolylhydrazidderivater og fremgangsmåde til fremstilling deraf
BG33292A3 (bg) Метод за получаване на пенамсулфоокисни производни
ATE127492T1 (de) Für photovernetzungsprozesse geeignete carbonylgruppenhaltige polyphosphazenderivate.
NZ223159A (en) Cycloalkyl - substituted 4 aminophenyl halo derivative and pharmaceutical compositions
PT83061B (pt) Processo para a preparacao de esteroides inibidores da aromatase
ATE9892T1 (de) Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen.
ES394972A1 (es) Procedimiento para la preparacion de nuevos 3 - alcohil - ariloximetilisoxazoles.
BG34454A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
ES463163A1 (es) Procedimiento para la obtencion de derivados de ferroceno.
ES375605A1 (es) Procedimiento para la obtencion de amino-6-hidracino - pi- ridacinas.
ES468133A1 (es) Procedimiento para preparar derivados del cornezuelo del centeno
SE8302084L (sv) Nya bensimidazolderivat
SU558061A1 (ru) Модификатор
BG28570A3 (bg) Метод за получаване на 1-фенил-2-амино-1,3-пропандиол-n алкилови производни
ES439006A1 (es) Procedimiento para la obtencion de nuevos derivados de 2- arilamino-2-imidazolina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102